New York Senate Bill S10299

New York 2025-2026 Regular Session

Caption

Authorizes licensed physicians to prescribe and order a non-patient specific order to a licensed pharmacist for sodium chloride nebulizer solution.

Summary

This bill amends the New York Education Law to expressly authorize licensed physicians to issue a non-patient-specific order to a licensed pharmacist for sodium chloride nebulizer solution, subject to regulations adopted by the commissioner and consistent with the Public Health Law. In practical terms, it creates a clear statutory basis for physicians to direct pharmacists to dispense this nebulizer solution without naming an individual patient in the order. The measure is narrow and technical, focused on one medication product used in respiratory care. It does not create a new benefit program or mandate coverage; rather, it clarifies who may prescribe or order sodium chloride nebulizer solution and how pharmacists may receive such orders under state law. The bill takes effect immediately upon enactment.

Impact

The bill would amend Education Law section 6527 by adding a new subdivision that specifically permits non-patient-specific orders for sodium chloride nebulizer solution from licensed physicians to licensed pharmacists. This would affect physician prescribing authority and pharmacist dispensing practices, while leaving implementation to commissioner regulations and consistency with the Public Health Law. The practical impact is to reduce legal ambiguity around dispensing this respiratory therapy product and to facilitate access through pharmacies.

Sentiment

Based on the bill text and available context, the overall sentiment appears neutral to favorable, with the proposal presented as a straightforward regulatory clarification rather than a controversial policy change. There are no recorded committee transcripts or votes indicating opposition or debate, and the bill’s narrow scope suggests it is intended to address a specific clinical and pharmacy practice issue. The absence of recorded controversy points to a likely technical consensus-oriented measure.

Contention

No specific points of contention are documented in the available materials. If any concerns were to arise, they would likely center on the scope of non-patient-specific prescribing authority, pharmacy dispensing procedures, or how commissioner regulations would implement the new authority. However, the provided record does not show any named opponents, amendments, or disputed issues.